FONDECYT REGULAR: |
|
|
|
|
1. Dr. Alberto Fierro |
Inmunidad y Trasplante |
CLC |
Generation of human regulatory T cells able to inhibit specifically the allogeneic immune response to the direct and indirect presentation pathways. |
Abril 2012- Marzo 2016 |
2. Dr. Francisco López |
Cáncer de Cólon |
CLC |
Importance of the EGF signaling pathway, microsatellite instability and tumoral lymphocytic infiltrate, in the dvelopment of metastasis in patients with colon cancer |
2011-2013 |
3. Dr. Rodrigo Quera |
Enf. Inflamatoria Intestinal |
CLC |
Role of ST2/IL33 system in mucosal inflammation an inflammatory bowel diseases patogenia. |
2011-2014 |
FONDECYT DE INICIO: |
|
|
|
|
4. Dra. Catherine Sánchez |
Cáncer de Próstata |
CLC |
Study of the role of secretory microRNAs from tumor stem cells in the mechanism of the primary and metastatic niche establishment in prostate cancer. |
Oct 2012- Sep 2015 |
5. Dr. Facundo Las Heras |
Células Msc cartílago |
CLC |
Sclerostin modulated mesenchymal stem cell derived chondrocytes facilitates cartilage repair. |
Oct 2013 - Sep 2016 |
6. Dr. Nicolás Crisosto |
Síndrome Ovario Poliquístico |
CLC |
Effect of testosterone on pro-inflammatory cytokine expression in pre-adipocytes from obese and non-obese women during reproductive age: a possible mechanism for insulin resistance in polycystic ovary syndrome. |
Oct 2013 - Sep 2016 |
FONDECYT REDES: |
|
|
|
|
8. Dr. Rodrigo Quera - Dra. Hermoso |
Enf. Inflamatoria Intestinal |
CLC |
Barts and the London School of medicine and dentistry. Blizard institute, Centre for Immunology and infectious disease |
2013 |